Preclinical Cardiac Safety Assessment of Drugs

ISSN： 1174-5886

Source： Drugs in R&D, Vol.8, Iss.4, 2007-01, pp. : 213-228

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Immunotoxicology: Role in the Safety Assessment of Drugs

By Jacques Descotes

Drug Safety, Vol. 28, Iss. 2, 2005-01 ,pp. : 127-136

Adis International

Access to resources Recommend Favorite

Assessment of safety of the major antimalarial drugs

By Chattopadhyay Rana Mahajan Babita Kumar Sanjai

Expert Opinion on Drug Safety, Vol. 6, Iss. 5, 2007-09 ,pp. : 505-521

Informa Healthcare

Access to resources Recommend Favorite

Capitalizing on Chemogenomic Concepts: Preclinical Safety Analysis to Help Develop Drugs, Not Duds

By Adis International Limited

Pharmaceutical & Diagnostic Innovation, Vol. 3, Iss. 5, 2005-01 ,pp. : 3-7

Adis International

Access to resources Recommend Favorite

Tissue-specific, non-invasive toxicity biomarkers: translation from preclinical safety assessment to clinical safety monitoring

By Muller Patrick Y Dieterle Frank

Expert Opinion on Drug Metabolism and Toxicology, Vol. 5, Iss. 9, 2009-09 ,pp. : 1023-1038

Informa Healthcare

Access to resources Recommend Favorite

Preclinical Investigation of the Safety of Eplir

By Saratikov A. Livshits N. Burchenkova F. Kadychagova N. Novozheeva T. Akhmedzhanov R. Perevozchikova T. Bashirova L.

Pharmaceutical Chemistry Journal, Vol. 39, Iss. 2, 2005-02 ,pp. : 64-66

Springer Publishing Company

Access to resources Recommend Favorite